NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica™, Inc. (NASDAQ: BIOC), a global provider of clinical trial management services, today announced the appointment of Garry D. Johnson as Senior Vice President and Chief Technology Officer (CTO), a newly created position.
